---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-081531"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2024-09-25T23:59:59+00:00"
generated_at: "2026-05-31T01:52:45.314952+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Unicycive Therapeutics regains compliance with Nasdaq minimum market value requirement

## Summary
- Nasdaq confirmed compliance with Listing Rule 5550(b)(2) on Sept 24, 2024 after market value exceeded $35M for 10 consecutive days.
- Market value was above $35M from Sept 10 to Sept 23, 2024, regaining compliance.
- Company had previously received a non-compliance notice on July 11, 2024 for failing to meet the minimum market value.
- Removes immediate risk of delisting from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-24-081531
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2024-09-25T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390024081531/0001213900-24-081531-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390024081531/ea0215583-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-081531
- JSON: https://secwatch.observer/filing/0001213900-24-081531.json
- Plain text: https://secwatch.observer/filing/0001213900-24-081531.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.